ariella

/Ariella Vaystooch

About Ariella Vaystooch

This author has not yet filled in any details.
So far Ariella Vaystooch has created 54 blog entries.

Oramed to Present at BIT’S 5th World Congress of Diabetes on July 13, 2017

JERUSALEM, July 12, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Dr. Miriam Kidron, Oramed's Chief Scientific Officer, will deliver a presentation titled, "Oral Insulin for Diabetes Treatment: [...]

2018-05-30T17:04:01+00:00 Categories: Press Releases|Tags: |

Oramed to Present at the American Diabetes Association 77th Scientific Sessions

JERUSALEM, June 6, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that a scientific abstract summarizing the recent Phase IIb study of its orally ingestible insulin capsule, ORMD-0801, will be presented [...]

2018-05-30T17:04:02+00:00 Categories: Press Releases|Tags: |

Oramed to Present at Conferences Next Week

JERUSALEM, May 18, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that  Chief Executive Officer, Nadav Kidron, will present at three conferences next week in Tel Aviv, Israel. Oppenheimer's 17th [...]

2018-05-30T17:04:02+00:00 Categories: Press Releases|Tags: |

Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017

JERUSALEM, March 22, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Dr. Miriam Kidron, Oramed's Chief Scientific Officer, will deliver a presentation titled, "Oral Insulin for Diabetes Treatment: [...]

2018-05-30T17:04:03+00:00 Categories: Press Releases|Tags: |

2016 Aegis Growth Conference

Company presentation by David Slager, Director of Oramed Date:               Wednesday, September 21, 2016 Time:              2:00pm PST Location:        The Encore at Wynn, 3. Life Science Room

2016-09-19T06:49:30+00:00 Categories: Events|

Oramed to Present at the Rodman & Renshaw Global Investment Conference

JERUSALEM, September 7, 2016 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming Rodman & Renshaw 18th Annual Global Investment Conference, taking place [...]

2018-05-30T17:04:05+00:00 Categories: Press Releases|Tags: |